- FRTX received a notice from Nasdaq stating its common stock will be suspended from trading on Nasdaq.
- This action followed the company's decision to withdraw an appeal and seek delisting from Nasdaq.
- From tariffs to inflation, macro risks are rising—Matt Maley reveals how he’s trading it all, live this Wednesday July 9 at 6 PM ET.
Fresh Tracks Therapeutics Inc FRTX shares are volatile Monday morning, trading higher by 3.2% to $0.84, after the company received a notice from Nasdaq stating its common stock will be suspended from trading on Nasdaq and is expected to move to an over-the-counter market.
This action followed the company's decision to withdraw an appeal and seek delisting from Nasdaq in preparation for a planned liquidation and dissolution.
Fresh Tracks says they've scheduled a stockholders' meeting to vote on the approval of the liquidation plan; the company says failure to approve it might lead to a judicial dissolution, which could be costly and reduce the cash distribution to stockholders during the company's dissolution.
See Also: Why U.S. Steel Shares Are Soaring Today
According to data from Benzinga Pro, FRTX has a 52-week high of $3.14 and a 52-week low of $0.45.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
